Worth reading
52Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Conditional
How definitive the wording is.Announced details
Applicable field (uses covered by this announcement)
Cosmetics aimed at maintaining skin immune homeostasis, research on skin diseases and infectious diseases, and future product development
Launch date27–29 March 2026 (actual: the period during which the 146th Annual Meeting of the Pharmaceutical Society of Japan was held)
Relationship between the counterparty and the company
IVY COSMETICS CORPORATION4918
Relationship with the Company
Joint Research
CounterpartyYamaguchi University Graduate School of MedicineDoshisha University Faculty of Life and Medical SciencesKogakuin University Faculty of Advanced Engineering
Impact on Business Performance
At this time, there is no impact on results for the current fiscal year
The company does not address Contract Value / Offering price.
| Item | Details |
|---|---|
| Counterparty | Yamaguchi University Graduate School of Medicine, Doshisha University Faculty of Life and Medical Sciences, Kogakuin University Faculty of Advanced Engineering |
| Relationship with the Company | Joint Research |
| Launch date | 27–29 March 2026 (actual: the period during which the 146th Annual Meeting of the Pharmaceutical Society of Japan was held) |
| Applicable area | Cosmetics aimed at maintaining skin immune homeostasis, research on skin diseases and infectious diseases, and future product development |
| Impact on Business Performance | At this time, there is no impact on results for the current fiscal year |
Items this document does not state (13)
Names of Products / Services CoveredCounterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historySource
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company presented research at the 146th Annual Meeting of the Pharmaceutical Society of Japan. The research findings are expected to have potential applications in cosmetics through the maintenance of skin immune homeostasis and to support future product development.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.